Medication & treatment

After a lengthy battle for access, Selexipag was approved as a treatment for pulmonary hypertension across the UK in April 2019. We caught up with Neil Hamilton, consultant pharmacist at the Sheffield Pulmonary Vascular Disease Unit, to sort the fact from the fiction.

Iain Armstrong, Chair of PHA UK, is joined by Carl, nurse specialist from Royal Brompton Hospital in London, and Sian, nurse specialist from Sheffield, to discuss IV treatment.

Iain Armstrong, Chair of PHA UK, sits down with nurse specialist Carl Harries and medical consultant Kostas Dimopoulos from the Royal Brompton Hospital in London to discuss Intravenous Therapy.

Patients respond to Chair of PHA UK Iain Armstrong’s question of whether they medicate to feel better or to live longer.